AstraZeneca’s COVID-19 vaccine significantly boosted antibody levels against Omicron

• AstraZeneca’s COVID-19 vaccine significantly boosted antibody levels against Omicron
• University of Oxford study supports use of AstraZeneca’s COVID-19 vaccine as third dose booster against Omicron
• Neutralising antibody levels against Omicron following a third dose boost of AstraZeneca’s COVID-19 vaccine were broadly similar to levels achieved after two doses against the Delta variant

Filinvest Group donates vaccine doses to Cebu City

Filinvest Development Corp. responds to the call of its partner local government units who aims to ramp up vaccination for their communities. FDC donated 2,000 AstraZeneca vaccine doses to the Office of the Mayor of Cebu City for New Normal Oasis Adaptation for a Home (NOAH), Cebu City’s vaccination program.